Study S002832

Effects of Pine Nut and Olive Oil as FFA1/FFA4 and GPR119 Agonists on Glucose Tolerance in Healthy Overweight or Obese Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03774095
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: UNKNOWN
Enrollment: 10
Start: 2018-06-11
Primary completion: 2018-12-30
Lead sponsor: Karina Vejrum Sørensen
Conditions: Type 2 Diabetes Mellitus; Obesity
Interventions: DIETARY_SUPPLEMENT:Hydrolyzed pine nut oil; DIETARY_SUPPLEMENT:Hydrolyzed pine nut oil and olive oil
Results posted: FALSE

Registered primary outcomes

Glucose [6 hours]
Insulin [6 hours]
C-peptide [6 hours]
GLP-1 [6 hours]
GIP [6 hours]
Ghrelin [6 hours]
Appetite [6 hours]
Gastrointestinal tolerability [24 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.